Publications by authors named "Andrew Chase"

Claim this Profile
G
Genome-wide analysis defines genetic determinants of MPN subtypes and identifies a sex-specific association at CDH22/CD40.
William J Tapper, Ahmed A Z Dawoud, Joannah Score, Andrew J Chase, E Joanna Baxter

Blood· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The JAK2 46/1 haplotype influences PD-L1 expression.
Gonzalo Carreño-Tarragona, María Tiana, Raquel Rouco, Alejandra Leivas, Jesús Victorino, Andrew J Chase

Blood· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathogenic variants causing ABL1 malformation syndrome cluster in a myristoyl-binding pocket and increase tyrosine kinase activity.
Alexander J M Blakes, Emily Gaul, Wayne Lam, Nora Shannon, Karen M Knapp, Andrew Chase

Eur J Hum Genet· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide association study identifies novel susceptibility loci for KIT D816V positive mastocytosis.
Gabriella Galatà, Andrés C García-Montero, Thomas Kristensen, Ahmed A Z Dawoud, Javier I Muñoz-González, Andrew J Chase

Am J Hum Genet· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutational mechanisms of EZH2 inactivation in myeloid neoplasms.
Andrew Chase, Joannah Score, Feng Lin, Catherine Bryant, Katherine Waghorn

Leukemia· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EZH2 in Myeloid Malignancies.
Jenny Rinke, Andrew Chase, Nicholas C P Cross, Andreas Hochhaus, Thomas Ernst

Cells· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PRR14L mutations are associated with chromosome 22 acquired uniparental disomy, age-related clonal hematopoiesis and myeloid neoplasia.
Andrew Chase, Andrea Pellagatti, Shalini Singh, Joannah Score, William J Tapper

Leukemia· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent activating STAT5B N642H mutation in myeloid neoplasms with eosinophilia.
Nicholas C P Cross, Yvette Hoade, William J Tapper, Gonzalo Carreno-Tarragona, Tiziana Fanelli, Andrew Chase

Leukemia· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel PCM1-PDGFRB Fusion in a Patient with a Chronic Myeloproliferative Neoplasm and an ins(8;5).
Muna Ghazzawi, Varun Mehra, Marcin Knut, Loretta Brown, William Tapper, Andrew Chase

Acta Haematol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms.
William Tapper, Amy V Jones, Robert Kralovics, Ashot S Harutyunyan, Katerina Zoi, Andrew Chase

Nat Commun· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Limited duration of complete remission on ruxolitinib in myeloid neoplasms with PCM1-JAK2 and BCR-JAK2 fusion genes.
Juliana Schwaab, Marcin Knut, Claudia Haferlach, Georgia Metzgeroth, Hans-Peter Horny, Andrew Chase

Ann Hematol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of methods to detect CALR mutations in myeloproliferative neoplasms.
Amy V Jones, Daniel Ward, Matthew Lyon, William Leung, Alison Callaway, Andrew Chase

Leuk Res· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangements.
Andrew Chase, Catherine Bryant, Joannah Score, Claudia Haferlach, Vera Grossmann

Haematologica· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Ponatinib as targeted therapy for FGFR1 fusions associated with the 8p11 myeloproliferative syndrome.
Andrew Chase, Catherine Bryant, Joannah Score, Nicholas C P Cross

Haematologica· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia.
Rocco Piazza, Simona Valletta, Nils Winkelmann, Sara Redaelli, Roberta Spinelli, Andrew J Chase

Nat Genet· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inactivation of polycomb repressive complex 2 components in myeloproliferative and myelodysplastic/myeloproliferative neoplasms.
Joannah Score, Claire Hidalgo-Curtis, Amy V Jones, Nils Winkelmann, Alison Skinner, Andrew Chase

Blood· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aberrations of EZH2 in cancer.
Andrew Chase, Nicholas C P Cross

Clin Cancer Res· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcription factor mutations in myelodysplastic/myeloproliferative neoplasms.
Thomas Ernst, Andrew Chase, Katerina Zoi, Katherine Waghorn, Claire Hidalgo-Curtis

Haematologica· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders.
Thomas Ernst, Andrew J Chase, Joannah Score, Claire E Hidalgo-Curtis, Catherine Bryant

Nat Genet· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The JAK2 46/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasms.
Amy V Jones, Peter J Campbell, Philip A Beer, Susanne Schnittger, Alessandro M Vannucchi, Andrew J Chase

Blood· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TFG, a target of chromosome translocations in lymphoma and soft tissue tumors, fuses to GPR128 in healthy individuals.
Andrew Chase, Thomas Ernst, Andreas Fiebig, Andrew Collins, Francis Grand

Haematologica· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A polymorphism associated with STAT3 expression and response of chronic myeloid leukemia to interferon α.
Sebastian Kreil, Katherine Waghorn, Thomas Ernst, Andrew Chase, Helen White

Haematologica· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fusion of PDGFRB to two distinct loci at 3p21 and a third at 12q13 in imatinib-responsive myeloproliferative neoplasms.
Claire Hidalgo-Curtis, Jane F Apperley, Allistair Stark, Michael Jeng, Jason Gotlib, Andrew Chase

Br J Haematol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A high-throughput candidate gene mutation screen in lymphoproliferative and myeloproliferative neoplasias.
Sebastian Kreil, Andreas Hochhaus, Nicholas C P Cross, Andrew Chase

Leuk Res· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms.
Francis H Grand, Claire E Hidalgo-Curtis, Thomas Ernst, Katerina Zoi, Christine Zoi, Andrew J Chase

Blood· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis